These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 22073373)
21. ZNF9 activation of IRES-mediated translation of the human ODC mRNA is decreased in myotonic dystrophy type 2. Sammons MA; Antons AK; Bendjennat M; Udd B; Krahe R; Link AJ PLoS One; 2010 Feb; 5(2):e9301. PubMed ID: 20174632 [TBL] [Abstract][Full Text] [Related]
22. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2). Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272 [TBL] [Abstract][Full Text] [Related]
23. Progression of muscle histopathology but not of spliceopathy in myotonic dystrophy type 2. Cardani R; Giagnacovo M; Rossi G; Renna LV; Bugiardini E; Pizzamiglio C; Botta A; Meola G Neuromuscul Disord; 2014 Dec; 24(12):1042-53. PubMed ID: 25139674 [TBL] [Abstract][Full Text] [Related]
24. Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes. Kim EY; Barefield DY; Vo AH; Gacita AM; Schuster EJ; Wyatt EJ; Davis JL; Dong B; Sun C; Page P; Dellefave-Castillo L; Demonbreun A; Zhang HF; McNally EM JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30730308 [TBL] [Abstract][Full Text] [Related]
25. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2. Ranum LP; Day JW Curr Neurol Neurosci Rep; 2002 Sep; 2(5):465-70. PubMed ID: 12169228 [TBL] [Abstract][Full Text] [Related]
26. ClC1 chloride channel in myotonic dystrophy type 2 and ClC1 splicing in vitro. Ursu SF; Alekov A; Mao NH; Jurkat-Rott K Acta Myol; 2012 Oct; 31(2):144-53. PubMed ID: 23097607 [TBL] [Abstract][Full Text] [Related]
27. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect. Bachinski LL; Udd B; Meola G; Sansone V; Bassez G; Eymard B; Thornton CA; Moxley RT; Harper PS; Rogers MT; Jurkat-Rott K; Lehmann-Horn F; Wieser T; Gamez J; Navarro C; Bottani A; Kohler A; Shriver MD; Sallinen R; Wessman M; Zhang S; Wright FA; Krahe R Am J Hum Genet; 2003 Oct; 73(4):835-48. PubMed ID: 12970845 [TBL] [Abstract][Full Text] [Related]
28. Cellular Senescence and Aging in Myotonic Dystrophy. Hasuike Y; Mochizuki H; Nakamori M Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216455 [TBL] [Abstract][Full Text] [Related]
29. Myotonic dystrophy type 2 and related myotonic disorders. Meola G; Moxley RT J Neurol; 2004 Oct; 251(10):1173-82. PubMed ID: 15503094 [TBL] [Abstract][Full Text] [Related]
30. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Kamsteeg EJ; Kress W; Catalli C; Hertz JM; Witsch-Baumgartner M; Buckley MF; van Engelen BG; Schwartz M; Scheffer H Eur J Hum Genet; 2012 Dec; 20(12):1203-8. PubMed ID: 22643181 [TBL] [Abstract][Full Text] [Related]
31. Nuclear ribonucleoprotein-containing foci increase in size in non-dividing cells from patients with myotonic dystrophy type 2. Giagnacovo M; Malatesta M; Cardani R; Meola G; Pellicciari C Histochem Cell Biol; 2012 Oct; 138(4):699-707. PubMed ID: 22706481 [TBL] [Abstract][Full Text] [Related]
32. Skeletal muscle involvement in myotonic dystrophy type 2. A comparative muscle ultrasound study. Tieleman AA; Vinke A; van Alfen N; van Dijk JP; Pillen S; van Engelen BG Neuromuscul Disord; 2012 Jun; 22(6):492-9. PubMed ID: 22414627 [TBL] [Abstract][Full Text] [Related]